000 01302 a2200289 4500
005 20250514204347.0
264 0 _c20050225
008 200502s 0 0 eng d
022 _a0167-8140
024 7 _a10.1016/j.radonc.2004.07.027
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCengiz, Mustafa
245 0 0 _aComment on: 'Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients' Radiother Oncol 70: 261-264, 2004 by Dr Rades et al.
_h[electronic resource]
260 _bRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
_cOct 2004
300 _a109; author reply 109-10 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAmifostine
_xadverse effects
650 0 4 _aHead and Neck Neoplasms
_xradiotherapy
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xradiotherapy
650 0 4 _aRadiation-Protective Agents
_xadverse effects
700 1 _aOnal, Cem
700 1 _aYildiz, Ferah
700 1 _aZorlu, A Faruk
773 0 _tRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
_gvol. 73
_gno. 1
_gp. 109; author reply 109-10
856 4 0 _uhttps://doi.org/10.1016/j.radonc.2004.07.027
_zAvailable from publisher's website
999 _c15156921
_d15156921